DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Jagsonpal Pharmaceuticals Limited — Board Meeting Intimation

NSE 2 hrs ago·21 Oct 2026, 12:42 pm

Jagsonpal Pharmaceuticals

Jagsonpal Pharmaceuticals has announced a board meeting scheduled for October 28, 2026. The primary agenda for this meeting is to review and approve the company's unaudited financial results for the first half of the fiscal year ending September 2026.

For investors, this announcement is a key update as it signals the release of interim financial data. This information is critical for assessing the company's current operational performance and financial health before the official results are disclosed to the public.

Market participants should monitor the release of these results closely. Any significant deviation in earnings or sales figures from market expectations could lead to volatility in the stock price, making this a significant event for shareholders to watch.